skip main navigation

Prostate

Early detection is key, in addition to monthly self exams, clinical exams and mammograms are important. If Breast Cancer runs in your family the above is even more critical.

The Hereditary Breast Cancer Resource at Creighton University is one of the largest, if not the largest resource in the world concerning hereditary breast/ovarian cancer families.
We have over 1,000 families in our resource at this time with over 100 families identified with a BRCA1 or BRCA2 genetic mutations.

Please refer to the family study process for the steps that are taken for a family to become involved in the HBOC Resource and the various studies. (family study process.)

After a family has been determined to have a hereditary pattern, one of the following syndrome diagnoses would be assigned to the family.

* Hereditary Breast Ovarian Cancer (HBOC): Two pre-menopausal breast cancers in more than one generation and one ovarian cancer diagnosed at any age.
* Hereditary Breast Cancer (HBC): Two pre-menopausal breast cancers in more than one generation.
* Hereditary Ovarian Cancer (HOVC): Two ovarian cancers at any age in more than one generation.

Individuals in these families are provided with screening recommendations (HCI Clinic) based on their family history and potentially invited to participate in genetic testing for BRCA1 and BRCA2 mutations.

Characteristics of Genes associated with HBOC:

 

Genes

Genetic features

 Clinical Features of Carriers

BRCA1

Discovered in 1990
Located on Chromosome 17
Isolated in 1994
Accounts for 40-50% of hereditary breast cancers

55-85% lifetime risk of developing breast cancer in women
28-44% lifetime risk of developing ovarian cancer
12-18% lifetime risk of developing prostate cancer
6% lifetime risk of developing breast cancer in men
Possible increased risk for colon cancer in men and women

BRCA2

Discovered in 1994
Located on Chromosome 13
Accounts for 33-50% of hereditary breast cancer
Less ovarian cancer occurrence than with BRCA1

33-85% lifetime risk of developing breast cancer in women
10-30% lifetime risk of developing ovarian cancer
4-14% lifetime risk of developing breast cancer in males
6-7% lifetime risk of developing pancreatic cancer
Possible increased risk of developing various other cancers (stomach, gallbladder/bileduct, malignant melanoma and prostate)

Creighton University